Why I wouldn't touch Novavax with a 10-foot pole

Novavax (NASDAQ: NVAX) was once a leading contender to dominate the coronavirus vaccine market. The company faced several ...

Triple-negative breast cancer vaccine shows promise in early clinical trial

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...
American Council on Science and Health

Will a Fentanyl Vaccine Work? We'll Know Soon

Fentanyl overdoses can happen in minutes, and the usual tools respond after the damage is already underway. A proposed ...
STAT

Results point to two immune signals, and possible methods to keep them from going awry

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

CDC study finds COVID shot significantly reduced ER visits for children

Results, published in the Morbidity and Mortality Weekly Report (MMWR), found the vaccine cut the the risk of ED/UC ...
STATOpinion

Now is the time to launch mpox vaccine booster trials

Patients want to know, “When should I get an mpox vaccine booster?” But the research to answer their question isn’t available ...
News-Medical.Net on MSN

Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data

Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...
New Scientist on MSN

New antibiotic could stave off drug-resistant gonorrhoea

Neisseria gonorrhoeae, the microbe responsible for gonorrhoea, is developing resistance to most antibiotics, which means we need new drugs to treat the condition. An antibiotic called zoliflodacin mig ...